Table 5.

On-therapy plus 1 day thromboembolic events (safety population)

Eltrombopag (N = 302)
All AEsSAEs
Patients with thromboembolic AEs, n (%)* 19 (6) 16 (5) 
Thromboembolic events, n (%) 24 (8) 18 (6) 
 Venous events 10 (3) 9 (3) 
 Arterial events 14 (5) 9 (3) 
Individual events, n (%)   
 Deep vein thrombosis 8 (3) 6 (2) 
 Cerebral infarction 4 (1) 3 (1) 
 Acute myocardial infarction 2 (<1) 2 (<1) 
 Myocardial infarction§ 3 (1) 3 (1) 
 Transient ischemic attack 3 (1) 
 Cerebral ischemia 1 (<1) 1 (<1) 
 Pulmonary embolism 1 (<1) 1 (<1) 
 Pulmonary infarction 1 (<1) 1 (<1) 
 Thrombophlebitis superficial 1 (<1) 1 (<1) 
Eltrombopag (N = 302)
All AEsSAEs
Patients with thromboembolic AEs, n (%)* 19 (6) 16 (5) 
Thromboembolic events, n (%) 24 (8) 18 (6) 
 Venous events 10 (3) 9 (3) 
 Arterial events 14 (5) 9 (3) 
Individual events, n (%)   
 Deep vein thrombosis 8 (3) 6 (2) 
 Cerebral infarction 4 (1) 3 (1) 
 Acute myocardial infarction 2 (<1) 2 (<1) 
 Myocardial infarction§ 3 (1) 3 (1) 
 Transient ischemic attack 3 (1) 
 Cerebral ischemia 1 (<1) 1 (<1) 
 Pulmonary embolism 1 (<1) 1 (<1) 
 Pulmonary infarction 1 (<1) 1 (<1) 
 Thrombophlebitis superficial 1 (<1) 1 (<1) 
*

Patients could have more than 1 event. Two patients had 2 events, and 2 other patients had 3 events, while on study. Two additional patients had 1 on-study event (a pulmonary embolism and a pulmonary infarction, respectively) and 1 off-study event (a deep vein thrombosis and a pulmonary infarction, respectively).

One patient had both a speech disorder and unsteadiness on the same day, and was later considered to have a transient ischemic attack.

One patient had 2 deep vein thromboses. Another patient was classified as having thrombosis and then later considered to have had a deep vein thrombosis.

§

One patient had 2 myocardial infarctions.